$BMEABiomea Fusion, Inc.

Active trials

• phase2Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapyrecruitingn=60
• phase2Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitusterminatedn=37
• N/AHuman Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)enrolling by invitationn=38
• phase1Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participantsactive not recruitingn=80
• phase2Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targetsrecruitingn=60
• phase1A Phase 1 Study of BMF-500 in Adults With Acute Leukemiaactive not recruitingn=35
• phase1Food Effect Study in Healthy Volunteerscompletedn=60
• phase2Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)completedn=443